New ways to estimate left heart pressures in people with heart failure and atrial fibrillation
Official title: Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation: A Prospective Multicenter Study
Run by Oslo University Hospital · NCT07436299 · Data updated 2026-11-12
This study tests a new approach that combines ultrasound and clinical data to see if doctors can better tell when the heart’s filling pressure is high in patients who have both heart failure and atrial fibrillation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 15 sites (Cleveland, Ohio and 14 other locations) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | January 2028 |
| Study ends | December 2029 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07436299 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with atrial fibrillation scheduled for invasive pressure measurement who can undergo echocardiography within eight hours of catheterization and have no recent cardiovascular medication changes.
✕Probably not a fit
Patients not undergoing catheterization or with exclusion criteria (e.g., significant valvular disease, prosthetic valves, pregnancy, LVAD, or non-cardiac comorbidity with poor prognosis) may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, multicenter observational study will enroll about 400 patients with atrial fibrillation who are undergoing right or left heart catheterization. It aims to develop and validate an algorithm that uses echocardiographic and clinical parameters to distinguish normal from elevated left ventricular filling pressure with at least 80% diagnostic accuracy. Secondary goals include identifying imaging predictors of abnormal pressure elevation during exercise and finding imaging markers linked to mortality and heart-failure outcomes over three years. Echocardiography will be performed in relation to catheterization, without changing cardiovascular medications within eight hours. An exercise substudy will explore predictors of increased wedge pressure during exertion.
Why it matters
Potential benefit: If successful, the algorithm could improve accuracy in diagnosing and predicting outcomes for HF patients with AF, potentially guiding treatment decisions.
How similar studies have gone: Prior multicenter AF studies support feasibility of large-gauge enrollment; however, this specific combined imaging-clinical algorithm for AF-related LVFP is novel but builds on established methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Atrial fibrillation (paroxysmal, persistent, or permanent) * Scheduled for RHC or LHC for clinical reasons * Able to undergo echocardiography and invasive pressure measurement within 8 hours * No cardiovascular medication changes between echo and catheterization * Written informed consent provided Exclusion Criteria: * Mitral stenosis or mitral annular calcification causing severe functional stenosis * Severe mitral or severe tricuspid regurgitation * Prosthetic mitral valve * Atrial fibrillation with rapid ventricular response \>120 bpm * Suboptimal echocardiographic imaging * Conditions rendering PCWP or LVEDP unreliable * Pregnant women * Complex congenital heart disease * LV assist device and patients with severe non-cardiac disease with poor prognosis * Cardiac transplant patients * End-stage liver disease
Where it's running
-
Division of Cardiovascular & Pulmonary Diseases, Oslo University Hospital
Oslo, Oslo, Norway Recruiting -
Cleveland Clinic
Cleveland, Ohio, United States Not yet recruiting -
Methodist DeBakey Heart and Vascular Center
Houston, Texas, United States Not yet recruiting -
Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium
Aalst, Belgium Not yet recruiting -
Catholic University of Leuven
Leuven, Belgium Not yet recruiting -
Laboratory Signal Processing and Image, Department of Cardiology
Rennes, France Not yet recruiting
Show 9 more locations
-
Service de Cardiologie, Hôpitaux Universitaires de Strasbourg
Strasbourg, France Not yet recruiting -
Nagoya City University Graduate School of Medical Sciences
Nagoya, Aichi-ken, Japan Not yet recruiting -
Ehime University
Tōon, Ehime, Japan Not yet recruiting -
University of Auckland
Auckland, Auckland, New Zealand Not yet recruiting -
Carol Davila University of Medicine and Pharmacy
Bucharest, Romania Not yet recruiting -
The Department of Cardiology at the Ljubljana University Medical Centre
Ljubljana, Slovenia Not yet recruiting -
Yonsei University College of Medicine
Seoul, Seoul, South Korea Not yet recruiting -
Department of Cardiovascular Sciences, University of Birmingham
Birmingham, United Kingdom Not yet recruiting -
King's College
London, United Kingdom Not yet recruiting
Study contacts
- Study coordinator: Lars-Egil Reine Hammersboen, Medical doctor
- Email: lerhammersboen@gmail.com
- Phone: +4790116941
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.